RxDoctor Payments Data

Heather Lawrence, PA

Medical · Greensburg, PANPI 1447581053

Payments from drug & device makers

$1,110in general payments, 2019–2025

Across 86 payments — averaging $12.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$198
  • Johnson & Johnson$127
  • AbbVie$118
  • GSK$109
  • Lilly USA, LLC$105
  • Boehringer Ingelheim$93
  • plus $359 from 13 others

What the payments were for

  • Food & beverage$1,110100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,110 in reported general payments places this provider in the 70th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$33,580
Medicare patients
146
Services billed
408

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban85$89,540
JardianceEmpagliflozin66$84,508
OzempicSemaglutide51$63,380
MounjaroTirzepatide41$48,867
XareltoRivaroxaban26$34,430
JanuviaSitagliptin Phosphate23$29,028
FarxigaDapagliflozin Propanediol20$23,118
TrulicityDulaglutide21$21,818
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$18,062
CreonLipase/Protease/Amylase11$14,946
Tresiba Flextouch U-100Insulin Degludec17$13,720
TradjentaLinagliptin18$11,840
MyrbetriqMirabegron14$8,083
LinzessLinaclotide13$6,580
Atorvastatin Calcium359$3,565

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$93$96,34884 claims
PfizerEliquis$64$89,54085 claims
Lilly USA, LLCMounjaro, Trulicity$105$70,68562 claims
Novo NordiskOzempic$198$63,38051 claims
Johnson & JohnsonXarelto$127$34,43026 claims
MerckJanuvia$15$29,02823 claims
AbbVieCreon, Linzess, Synthroid$118$23,64781 claims
AstraZenecaFarxiga$25$23,11820 claims
GSKTrelegy Ellipta$109$18,06228 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Greensburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →